These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 1686205

  • 1. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L, Field MJ, Hughes J, Menzies R, Oles RJ, Vass CA, Woodruff GN.
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [Abstract] [Full Text] [Related]

  • 2. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1130-3. PubMed ID: 1996314
    [Abstract] [Full Text] [Related]

  • 3. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
    Mosher JT, Johnson MF, Birkemo LS, Ervin GN.
    Peptides; 1996 Feb 15; 17(3):483-8. PubMed ID: 8735976
    [Abstract] [Full Text] [Related]

  • 4. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L, Mennuni L, Garofalo P, Makovec F.
    Behav Pharmacol; 1998 May 15; 9(3):183-94. PubMed ID: 9832933
    [Abstract] [Full Text] [Related]

  • 5. Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
    Frankland PW, Josselyn SA, Bradwejn J, Vaccarino FJ, Yeomans JS.
    J Neurosci; 1997 Mar 01; 17(5):1838-47. PubMed ID: 9030642
    [Abstract] [Full Text] [Related]

  • 6. The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.
    Singh L, Field MJ, Vass CA, Hughes J, Woodruff GN.
    Br J Pharmacol; 1992 Jan 01; 105(1):8-10. PubMed ID: 1350747
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
    Ballaz S, Barber A, Fortuño A, Del Río J, Martin-Martínez M, Gómez-Monterrey I, Herranz R, González-Muñiz R, García-López MT.
    Br J Pharmacol; 1997 Jun 01; 121(4):759-67. PubMed ID: 9208145
    [Abstract] [Full Text] [Related]

  • 8. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 01; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 9. The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
    Bickerdike MJ, Marsden CA, Dourish CT, Fletcher A.
    Eur J Pharmacol; 1994 Dec 27; 271(2-3):403-11. PubMed ID: 7705440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.
    Hendrie CA, Neill JC, Shepherd JK, Dourish CT.
    Physiol Behav; 1993 Oct 27; 54(4):689-93. PubMed ID: 7902586
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CholecystokininB receptor antagonist increases food intake in rats.
    Dorré D, Smith GP.
    Physiol Behav; 1998 Aug 27; 65(1):11-4. PubMed ID: 9811359
    [Abstract] [Full Text] [Related]

  • 14. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B, Vaidya AH, Rosenthal DI, Hochman C, Crooke JJ, DeLuca S, DeVine A, Cheo-Isaacs CT, Carter AR, Jordan AD, Reitz AB, Shank RP.
    J Pharmacol Exp Ther; 2002 Nov 27; 303(2):777-90. PubMed ID: 12388665
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
    Berthelot V, Belzung C, Meunier-Salaun MC, Nowak R, Picard M.
    Physiol Behav; 1996 Aug 27; 60(2):575-9. PubMed ID: 8840921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
    Vasar E, Lang A, Harro J, Bourin M, Bradwejn J.
    Neuropharmacology; 1994 Jun 27; 33(6):729-35. PubMed ID: 7936110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.